Cetuximab MMAE
Product Specifications
Target
Antibody-Drug Conjugates (ADCs), EGFR, Microtubule Associated
Related Pathways
Angiogenesis, Cytoskeletal Signaling, JAK/STAT signaling, Antibody-drug Conjugate/ADC Related, Tyrosine Kinase/Adaptors
Bioactivity
Cetuximab-MMAE, an antibody-drug conjugate (ADC), combines an EGFR-targeting antibody with Monomethyl auristatin E (MMAE) to investigate colorectal and head and neck cancers.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog